David H. Clarke is CEO & Director at INNOVATE BIOPHARMACEUTICALS, INC. (INNT). They have made 1 open-market trade across 1 company since 2016, most recently 2018-01-26.
CIK 0001251818
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $807K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INNT | BUY | 2016-07-13 | 2018-03-13 | $0.55 | $807K | +42.5% | +55.3% | -42.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.